Global variability of influenza activity and virus subtype circulation from 2011 to 2023

Background Although decreased influenza activity has been reported in many countries during the COVID-19 pandemic, it remains unknown how global influenza activity has changed. We described the global variability of influenza activity and virus subtype circulation from 2011 to 2023 to prepare for the potential influenza outbreak with the control of the COVID-19 pandemic. Methods Influenza virological surveillance data between 2011 and 2023 were obtained from the WHO-FluNet database. We first calculated and compared the influenza activity before and during the COVID-19 pandemic. For countries whose influenza activity has recovered, we also described changes in the duration of influenza epidemics. We then determined the proportion of influenza cases caused by the different influenza virus types. Results In total, 73 countries with 2.17 million influenza cases were included. In the early stage of the COVID-19 pandemic, decreased influenza activity was observed in all WHO regions. In 2022 and 2023, rebound in influenza activity was observed in all WHO regions, especially in Western Pacific Region. At the same time, a change in the duration of the influenza epidemic was observed in several Southern Hemisphere countries. Moreover, in all WHO regions, few B/Yamagata viruses were detected during the COVID-19 pandemic. Conclusions Lack of exposure to influenza will diminish population immunity and increase the severity of large epidemics on a future global resurgence. Ongoing monitoring of the changes in the duration of the influenza epidemic and circulation subtypes should be the focus of future work.

[1]  New recommendations for the composition of influenza vaccines in 2023 for the southern hemisphere. , 2022, Saudi medical journal.

[2]  J. Paget,et al.  Has influenza B/Yamagata become extinct and what implications might this have for quadrivalent influenza vaccines? , 2022, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[3]  Jie Wu,et al.  Changes in Influenza Activity and Circulating Subtypes During the COVID-19 Outbreak in China , 2022, Frontiers in Medicine.

[4]  J. Paget,et al.  Global patterns of seasonal influenza activity, duration of activity and virus (sub)type circulation from 2010 to 2020 , 2022, Influenza and other respiratory viruses.

[5]  B. Kuehn Influenza Vaccination Increased During the COVID-19 Pandemic. , 2021, JAMA.

[6]  K. Laurie,et al.  Influenza lineage extinction during the COVID-19 pandemic? , 2021, Nature Reviews Microbiology.

[7]  John K Billington,et al.  Vaccine complacency and dose distribution inequities limit the benefits of seasonal influenza vaccination, despite a positive trend in use , 2021, Vaccine.

[8]  Jiang Li,et al.  Risk of infection and transmission of SARS-CoV-2 among children and adolescents in households, communities and educational settings: A systematic review and meta-analysis , 2021, Journal of global health.

[9]  Zhongjie Li,et al.  Impact of COVID-19 outbreaks and interventions on influenza in China and the United States , 2021, Nature Communications.

[10]  Gregory L. Watson,et al.  An evidence review of face masks against COVID-19 , 2021, Proceedings of the National Academy of Sciences.

[11]  Reynold Cheng,et al.  Effects of human behaviour changes during the COVID-19 pandemic on influenza spread in Hong Kong , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  L. Brammer,et al.  Decreased influenza activity during the COVID-19 pandemic—United States, Australia, Chile, and South Africa, 2020 , 2020, American Journal of Transplantation.

[13]  Soyeon Ahn,et al.  Impact of Public Health Interventions on Seasonal Influenza Activity During the SARS-CoV-2 Outbreak in Korea , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  P. Ueda,et al.  Seasonal Influenza Activity During the SARS-CoV-2 Outbreak in Japan. , 2020, JAMA.

[15]  M. Chen,et al.  Passive immune therapy and other immunomodulatory agents for the treatment of severe influenza: Systematic review and meta‐analysis , 2019, Influenza and other respiratory viruses.

[16]  S. Madhi,et al.  Global patterns in monthly activity of influenza virus, respiratory syncytial virus, parainfluenza virus, and metapneumovirus: a systematic analysis. , 2019, The Lancet. Global health.

[17]  H. Ye,et al.  Structural Insights for Anti-Influenza Vaccine Design , 2019, Computational and structural biotechnology journal.

[18]  J. Peiris,et al.  Indirect protection from vaccinating children against influenza in households , 2019, Nature Communications.

[19]  M. L. Matute,et al.  Distribution of influenza virus types by age using case-based global surveillance data from twenty-nine countries, 1999-2014 , 2018, BMC Infectious Diseases.

[20]  Jan Kyncl,et al.  Estimates of global seasonal influenza-associated respiratory mortality: a modelling study , 2017, The Lancet.

[21]  O. Pybus,et al.  Genome-wide evolutionary dynamics of influenza B viruses on a global scale , 2017, PLoS Pathogens.

[22]  D. Krewski,et al.  Effectiveness of personal protective measures in reducing pandemic influenza transmission: A systematic review and meta-analysis. , 2017, Epidemics.

[23]  Daniel Krewski,et al.  Reviewing the History of Pandemic Influenza: Understanding Patterns of Emergence and Transmission , 2016, Pathogens.

[24]  L. Brammer,et al.  Correction: Temporal Patterns of Influenza A and B in Tropical and Temperate Countries: What Are the Lessons for Influenza Vaccination? , 2016, PloS one.

[25]  M. L. Matute,et al.  Temporal Patterns of Influenza A and B in Tropical and Temperate Countries: What Are the Lessons for Influenza Vaccination? , 2016, PloS one.

[26]  P. Zucs,et al.  Age-specific differences in influenza virus type and subtype distribution in the 2012/2013 season in 12 European countries , 2015, Epidemiology and Infection.

[27]  Timothy B. Stockwell,et al.  The contrasting phylodynamics of human influenza B viruses , 2015, eLife.

[28]  F. Pozo,et al.  Decline in influenza vaccine effectiveness with time after vaccination, Navarre, Spain, season 2011/12. , 2013, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[29]  Stephen A. Martin,et al.  Exercise and Respiratory Tract Viral Infections , 2009, Exercise and sport sciences reviews.

[30]  L. Melcher Recommendations for influenza and pneumococcal vaccinations in people receiving chemotherapy. , 2005, Clinical oncology (Royal College of Radiologists (Great Britain)).